Pfizer (PFE) Tops Q3 EPS by 3c
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.72 --0%
EPS Growth %: -12.8%
Financial Fact:
Income from continuing operations: 1.32B
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -12.8%
Financial Fact:
Income from continuing operations: 1.32B
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q3 EPS of $0.78, $0.03 better than the analyst estimate of $0.75. Revenue for the quarter came in at $13.3 billion versus the consensus estimate of $13.53 billion.
GUIDANCE:
- Pfizer sees FY2018 EPS of $2.98-$3.02, versus the consensus of $2.99.
- Now Expect to Repurchase Approximately $12 Billion of Shares in 2018
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Pfizer executive says China now leads Europe in drug innovation
- Litchfield Hills Starts NextPlat (NXPL) at Buy
Create E-mail Alert Related Categories
Earnings, Guidance, Stock BuybacksRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
